Dharmendrabhai Becharbhai Jasani acquired 1,11,341 equity shares of Hemo Organic Limited through an on-market transaction on September 7, 2026. This acquisition increased his combined holding with persons acting in concert to 6.84% of the company's voting capital.

The disclosure was filed with BSE Limited under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Jasani is not part of the promoter or promoter group of Hemo Organic Limited.

Acquisition details

The acquirer purchased shares directly in the open market. The Persons Acting in Concert (PACs) include Jasani Family Private Trust, Heemaben Makadia, Ayush Dharmendrabhai Jasani, and Ketanaben Jasani. No shares were acquired by the PAC entities during this specific transaction period.

Shareholding structure

Prior to this transaction, the aggregate holding of Jasani and his PACs stood at 1,26,073 shares, representing 3.63% of the total voting capital. Following the acquisition, the total holding rose to 2,37,414 shares.

The company's total equity share capital remained unchanged at 34,65,900 equity shares of ₹10 each, aggregating to ₹3,46,59,000. The total diluted share capital, assuming full conversion of outstanding convertible securities, stands at 68,65,900 equity shares of ₹10 each, aggregating to ₹6,86,59,000.

What the numbers show

The acquisition represents a significant single-step increase in ownership, adding 3.21% to the voting capital stake. The gap between the percentage of voting capital (6.84%) and diluted capital (3.45%) post-acquisition highlights the presence of substantial convertible instruments or warrants outstanding in Hemo Organic Limited, which dilute the effective equity ownership percentage relative to the current voting power.

Hemo Organic Limited promoters Dineshbhai Shanabhai Patel and Sonalben Dineshbhai Patel have collectively divested 11.88% of the company's total share capital through off-market sales on September 23 and September 24, 2026.

The latest disclosure filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, confirms that Dineshbhai Patel sold an additional 60,000 shares (1.73%) on September 24, 2026. This transaction follows his disposal of 3,11,972 shares (9.00%) and Sonalben Patel's sale of 40,000 shares (1.15%) on September 23, 2026.

Shareholding movement

The table below captures the change in Dineshbhai Patel's shareholdings following the sequential disposals:

Sonalben Patel's holding remained unchanged at 0.21% after her single-day disposal on September 23. The total equity share capital of Hemo Organic remains unchanged at 34,65,900 equity shares of ₹10 each, aggregating to ₹3,46,59,000. The fully diluted share capital stands at 68,65,900 equity shares of ₹10 each, aggregating to ₹6,86,59,000, assuming full conversion of all outstanding convertible securities and warrants.

Context: broader promoter stake sale

These daily disposals form part of a wider promoter divestment strategy. Separately, Dineshbhai Patel and Sonalben Patel entered into share purchase agreements on September 22, 2026 to sell a combined 16.38% equity stake, comprising 5,67,958 fully paid-up equity shares, to the Jasani Family Trust and other buyers via an off-market route.

The buyers under those agreements include Mrs. Ketanaben Jasani, Mrs. Heema Makadia, M/s. V9BIZ Business Solution LLP, and Jasani Family Trust. None of the buyers are related to the promoter or promoter group, and the transactions do not fall within the definition of related party transactions. The share purchase agreements do not confer any special rights on the buyers, including no right to appoint directors, affirmative voting rights, veto rights, or pre-emptive rights.

Regulatory disclosures

The September 23 and September 24, 2026 disposals were disclosed to BSE Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The broader stake sale was disclosed to the exchanges under Regulation 30 and Regulation 30A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, referencing the SEBI Master Circular dated January 30, 2026. Hemo Organic is listed on BSE Limited.